title: Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection.
authors.affiliation: Department of Internal Medicine, Limoges University Hospital, Limoges, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Loustaud-Ratti
authors.forename: Eric
authors.initials: E
authors.lastname: Liozon
authors.forename: Hussein
authors.initials: H
authors.lastname: Karaaslan
authors.forename: Sophie
authors.initials: S
authors.lastname: Alain
authors.forename: François
authors.initials: F
authors.lastname: Paraf
authors.forename: Yannick
authors.initials: Y
authors.lastname: Le Meur
authors.forename: François
authors.initials: F
authors.lastname: Denis
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Vidal
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage*; D003449:Cryoglobulinemia / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy* / Q000821:virology*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008875:Middle Aged; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin